Open Orphan Plc
ORPH.LN
Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Open Orphan comprises of two commercial specialist CRO services businesses; hVIVO and Venn Life Sciences and has offices in London, Dublin, Paris, and the Netherlands. Open Orphan is led by a management team with deep industry and financial experience.
![](https://files.valuethemarkets.com/containers/assets/images/2020/07/Open-Orphan-Logo.jpg/3315cb54fb6176bc099fc3483ac02b19.jpg)
Related content
![](https://files.valuethemarkets.com/containers/assets/images/2021/01/Open-Orphan-20-01-21-HERO-v1.jpg/b024d61366b7e350d0c97b557688e688.jpg)
Press Releases
|
Open Orphan expands human challenge trial capacity with new volunteer recruitment centres
![](https://files.valuethemarkets.com/containers/assets/images/2021/01/Open-Orphan-11-01-21-HERO-v1.jpg/52aec34a75db95670e3d30cfdd2b585c.jpg)
Press Releases
|
Open Orphan and hVIVO’s human vaccine trial for Covid-19 begins
![](https://files.valuethemarkets.com/containers/assets/images/2021/01/Open-Orphan-06-01-21-HERO-v1.jpg/e215e6eaaea50a8a9af17c00302f7486.jpg)
Press Releases
|
Open Orphan has a great start to 2021 with key 12-month contract renewal
![](https://files.valuethemarkets.com/containers/assets/images/2020/12/Open-Orphan-23-12-20-HERO-v1.jpg/5452ba2d7ab55da3393620f552cb26ba.jpg)
Press Releases
|
Open Orphan wins vaccine contract extension and announces toxicology study completion
![](https://files.valuethemarkets.com/containers/assets/images/2020/12/Open-Orphan-21-12-20-HERO-v1.jpg/45ad838a7da8ca7e39bcc3bbe53acbdd.jpg)
Press Releases
|
“We are scaling-up rapidly and at minimum expense” – Open Orphan’s Cathal Friel on the pharma services firm’s exciting plans for 2021 and beyond
![](https://files.valuethemarkets.com/containers/assets/images/2020/12/Open-Orphan-14-12-20-HERO-v1.jpg/1366413828797a278938929275f1c0f8.jpg)
Press Releases
|
Open Orphan and Codagenix receive MHRA approval for Covid vaccine challenge study
![](https://files.valuethemarkets.com/containers/assets/images/2020/12/Open-Orphan-07-12-20-HERO-v1.jpg/196744736d3f40df2f80a4e68b230d9e.jpg)
Press Releases
|
Open Orphan continues to convert deal pipeline with key Venn contracts
![](https://files.valuethemarkets.com/containers/assets/images/2020/11/Open-Orphan-24-11-20-HERO-v1.jpg/235ba2ce58d55e2d8e21b04a5bab0ba8.jpg)
Press Releases
|
Open Orphan strengthens board with Elaine Sullivan hire
![](https://files.valuethemarkets.com/containers/assets/images/2020/11/Open-Orphan-19-11-20-HERO-v1.jpg/9d98560e697cd4f34891c9fa8f9d62c0.jpg)
Press Releases
|
Open Orphan leads weighty Wellcome Trust bid to define human challenge drug standards
![](https://files.valuethemarkets.com/containers/assets/images/2020/11/Open-Orphan-05-11-20-HERO-v1.jpg/3de45922e1ffe1a4446abb6498911da8.jpg)
Press Releases
|
Open Orphan lands another £2.5m flu challenge study contract
![](https://files.valuethemarkets.com/containers/assets/images/2020/10/Open-Orphan-30-10-20-HERO-v1.jpg/a78cd904fa9beefa034d1f67ed51db21.jpg)
Press Releases
|
Open Orphan extends pharmacometrics relationship with tier 1 German pharma company
![](https://files.valuethemarkets.com/containers/assets/images/2020/10/Open-Orphan-20-10-20-HERO-v1.jpg/9bd90d625906648602c9262a26561e8c.jpg)
Press Releases
|
Open Orphan reveals transformational Covid-19 vaccine contract with UK government
![](https://files.valuethemarkets.com/containers/assets/images/2020/09/Open-Orphan-28-09-20-HERO.jpg/34d14b115f24871f3291d3da8828d358.jpg)
Press Releases
|
Open Orphan hits record highs after winning £4.3m vaccine contract
![](https://files.valuethemarkets.com/containers/assets/images/2019/11/Orph-lower-brightness.jpg/bbff890ed058acbce488c8585a711a44.jpg)
Press Releases
|
Key human challenge expert Adrian Wildfire rejoins hVIVO for Open Orphan boost (ORPH)
![open-orphan-profits.](https://files.valuethemarkets.com/containers/assets/images/2020/01/pharmaceuticals.jpg/86cb3249dffcd9ebc2b7fa23dcef820f.jpg)
Investing Ideas
|
Open Orphan reveals placing progress following hVIVO merger (ORPH)
![open-orphan-profits.](https://files.valuethemarkets.com/containers/assets/images/2020/01/pharmaceuticals.jpg/86cb3249dffcd9ebc2b7fa23dcef820f.jpg)
Investing Ideas
|